Calico Life Sciences

American biotechnology company in South San Francisco, California, founded in 2013 by Google, now Alphabet, to study the biology of ageing and the diseases that come with it. Runs discovery research in cell biology, genetics and computational biology with model organisms and human genetics, develops medicines in neurodegeneration, oncology and age related disease, and works in a long running research and development partnership with AbbVie that funds and commercialises its clinical programmes.